Haplotype-based case-control study on human apurinic/apyrimidinic endonuclease 1/redox effector factor-1 gene and essential hypertension

American Journal of Hypertension

Volumn 23, Issue 2, 2010, Pages 186-191

  Naganuma, Takahiro ^a,b   Nakayama, Tomohiro ^a   Sato, Naoyuki ^a   Fu, Zhenyan ^a,c   Soma, Masayoshi ^a   Yamaguchi, Mai ^a   Shimodaira, Masanori ^a   Aoi, Noriko ^a   Usami, Ron ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOYO UNIVERSITY   (Japan)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apurinic apyrimidinic endonuclease 1 redox effector factor 1; Blood pressure; Case control study; Essential hypertension; Haplotype; Hypertension; Single nucleotide polymorphism

Indexed keywords

DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; REDOX EFFECTOR FACTOR 1;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALLELES; BLOOD PRESSURE; CASE-CONTROL STUDIES; DNA DAMAGE; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; JAPAN; LINKAGE DISEQUILIBRIUM; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 75549085573     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2009.221     Document Type: Article

References (32)

1. Umemoto S, Tanaka M, Kawahara S, Kubo M, Umeji K, Hashimoto R, Matsuzaki M. Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27:877-885.
2. Tanaka M, Umemoto S, Kawahara S, Kubo M, Itoh S, Umeji K, Matsuzaki M. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats. Hypertens Res 2005; 28:67-77.
3. Negishi H, Ikeda K, Kuga S, Noguchi T, Kanda T, Njelekela M, Liu L, Miki T, Nara Y, Sato T, Mashalla Y, Mtabaji J, Yamori Y. The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania. J Hypertens 2001; 19:529-533.
4. Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1. Mutat Res 2000; 461: 83-108.
5. Qu J, Liu GH, Huang B, Chen C. Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of cysteines 93 and 310. Nucleic Acids Res 2007; 35: 2522-2532.
6. Fritz G. Human APE/Ref-1 protein. Int J Biochem Cell Biol 2000; 32:925-929.
7. Yang S, Irani K, Heffron SE, Jurnak F, Meyskens FL Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 2005; 4:1923-1935.
8. Robson CN, Hochhauser D, Craig R, Rack K, Buckle VJ, Hickson ID. Structure of the human DNA repair gene HAP1 and its localisation to chromosome 14q 11.2-12. Nucleic Acids Res 1992; 20:4417-4421.
9. Xanthoudakis S, Miao GG, Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. Proc Natl Acad Sci USA 1994; 91:23-27.
10. Jeon BH, Gupta G, Park YC, Qi B, Haile A, Khanday FA, Liu YX, Kim JM, Ozaki M, White AR, Berkowitz DE, Irani K. Apurinic/apyrimidinic endonuclease 1 regulates endothelial NO production and vascular tone. Circ Res 2004; 95:902-910.
11. Patterson C. Blood pressure control goes nuclear. Circ Res 2004; 95:849-851.
12. Volpe M, Alderman MH, Furberg CD, Jackson R, Kostis JB, Laragh JH, Psaty BM, Ruilope LM. Beyond hypertension toward guidelines for cardiovascular risk reduction. Am J Hypertens 2004; 17:1068-1074.
13. Dominiczak A F, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY. Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35:164-172.
14. Sano M, Kuroi N, Nakayama T, Sato N, Izumi Y, Soma M, Kokubun S. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens 2005; 18:403-408.
15. Fu Z, Nakayama T, Sato N, Izumi Y, Kasamaki Y, Shindo A, Ohta M, Soma M, Aoi N, Sato M, Matsumoto K, Ozawa Y, Ma Y. A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men. Am J Hypertens 2008; 21:1216-1223.
16. Chang-Claude J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Schmezer P, Ambrosone CB. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 2005; 11:4802-4809.
17. Su D, Ma S, Liu P, Jiang Z, Lv W, Zhang Y, Deng Q, Smith S, Yu H. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer 2007; 56:281-288. (Pubitemid 46590484)
18. Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, Polakova V, Hanova M, Slyskova J, Tulupova E, Kumar R, Bortlik M, Barale R, Hemminki K, Vodicka P. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res 2008; 638:146-153.
19. Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T. Association study using single nucleotide polymorphisms in the estrogen receptor beta (ESR2) gene for preeclampsia. Hypertens Res 2004; 27:903-909.
20. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet 1995; 9:341-342.
21. Kobayashi Y, Nakayama T, Sato N, Izumi Y, Kokubun S, Soma M. Haplotype-based case-control study revealing an association between the adrenomedullin gene and proteinuria in subjects with essential hypertension. Hypertens Res 2005; 28:229-236.
22. Morita A, Nakayama T, Doba N, Hinohara S, Soma M. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP level and arterial pulse wave velocity in healthy elderly Japanese. Hypertens Res 2006; 29:323-331.
23. Hui P, Nakayama T, Morita A, Sato N, Hishiki M, Saito K, Yoshikawa Y, Tamura M, Sato I, Takahashi T, Soma M, Izumi Y, Ozawa Y, Cheng Z. Common single nucleotide polymorphisms in Japanese patients with essential hypertension: aldehyde dehydrogenase 2 gene as a risk factor independent of alcohol consumption. Hypertens Res 2007; 30:585-592.
24. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002; 106:927-932.
25. Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T. Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 2002; 32: 650-654.
26. Zhang K, Calabrese P, Nordborg M, Sun F. Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 2002; 71:1386-1394.
27. Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 2002; 23:221-233.
28. Sharma P, Hingorani A, Jia H, Hopper R, Brown MJ. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension. J Hypertens 1999; 17:1281-1287.
29. Ombra MN, Forabosco P, Casula S, Angius A, Maestrale G, Petretto E, Casu G, Colussi G, Usai E, Melis P, Pirastu M. Identification of a new candidate locus for uric acid nephrolithiasis. Am J Hum Genet 2001; 68:1119-1129.
30. Morita A, Nakayama T, Soma M, Mizutani T. Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am J Hypertens 2007; 20:527-532.
31. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
32. Misawa K, Fujii S, Yamazaki T, Takahashi A, Takasaki J, Yanagisawa M, Ohnishi Y, Nakamura Y, Kamatani N. New correction algorithms for multiple comparisons in case-control multilocus association studies based on haplotypes and diplotype configurations. J Hum Genet 2008; 53:789-801.